Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis?

Elżbieta Kuroczycka-Saniutycz1, Tadeusz Porowski, Piotr T Protas

  • 1Department of Pediatrics and Nephrology, Medical University of Białystok, ul. Waszyngtona 17, 15-274, Białystok, Poland, e.kuroczycka@wp.pl.

Insights

Hyperuricemia in children with urolithiasis is linked to lower excretion of urinary crystallization inhibitors. Obesity did not directly impact the lithogenic risk profile in this pediatric cohort.

Area of Science:

  • Pediatric Nephrology
  • Urology
  • Metabolic Disorders

Background:

  • Obesity and hyperuricemia are suspected factors in urinary stone formation.
  • Understanding their impact on pediatric urolithiasis is crucial.

Purpose of the Study:

  • To investigate the effect of obesity and hyperuricemia on the urinary lithogenic risk profile in children with urolithiasis.

Main Methods:

  • Compared lithogenic profiles in pediatric urolithiasis patients with and without hyperuricemia.
  • Analyzed effects of overweight/obesity versus normal weight on lithogenic parameters.
  • Utilized a cohort of 478 children with urolithiasis and 517 healthy controls.

Main Results:

  • Hyperuricemia in pediatric urolithiasis patients correlated with significantly lower urinary excretion of crystallization inhibitors (citrates, magnesium).
  • Negative correlations were observed between serum uric acid levels and urine citrate/creatinine and magnesium/creatinine ratios.
  • No significant differences in urinary stone risk parameters were found between overweight/obese and normal-weight pediatric urolithiasis patients.

Conclusions:

  • Hyperuricemia is associated with reduced urinary excretion of crystallization inhibitors in pediatric stone formers.
  • Obesity did not show a direct influence on the lithogenic risk profile in this pediatric cohort.
  • Further research is needed to confirm the clinical relevance of these findings and explore potential links between elevated serum uric acid, renal function, and lithogenic parameters.
Abstract

Related Concept Videos

Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
709
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
1.0K
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
375
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
352
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
795